Bye-bye muscle biopsy, we have autoantibodies with us now

Muscle biopsy is generally considered the gold standard diagnostic tool for patients with presenting with features suggestive of idiopathic inflammatory myopathy. Muscle biopsy is however an invasive test, the histopathological findings can be influenced by previous treatment and not all patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria Riddell, Sarah L Tansley
Format: Article
Language:English
Published: SAGE Publishing 2020-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=74;epage=80;aulast=Riddell
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568799478415360
author Victoria Riddell
Sarah L Tansley
author_facet Victoria Riddell
Sarah L Tansley
author_sort Victoria Riddell
collection DOAJ
description Muscle biopsy is generally considered the gold standard diagnostic tool for patients with presenting with features suggestive of idiopathic inflammatory myopathy. Muscle biopsy is however an invasive test, the histopathological findings can be influenced by previous treatment and not all patients with myositis spectrum disease have muscle involvement. Myositis specific and associated autoantibodies can now be identified in the majority of patients with myositis. When present they identify homogeneous patient subgroups and have the potential to be key tools in developing a personalised approach to disease management. Here we review the utility of myositis specific and associated autoantibodies as diagnostic and prognostic tools.
format Article
id doaj-art-b3698a7c2a15429caf5604b708231644
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2020-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-b3698a7c2a15429caf5604b7082316442025-02-03T00:25:16ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012020-01-01156748010.4103/injr.injr_114_20Bye-bye muscle biopsy, we have autoantibodies with us nowVictoria RiddellSarah L TansleyMuscle biopsy is generally considered the gold standard diagnostic tool for patients with presenting with features suggestive of idiopathic inflammatory myopathy. Muscle biopsy is however an invasive test, the histopathological findings can be influenced by previous treatment and not all patients with myositis spectrum disease have muscle involvement. Myositis specific and associated autoantibodies can now be identified in the majority of patients with myositis. When present they identify homogeneous patient subgroups and have the potential to be key tools in developing a personalised approach to disease management. Here we review the utility of myositis specific and associated autoantibodies as diagnostic and prognostic tools.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=74;epage=80;aulast=Riddellautoantibodybiopsydiagnosismyopathymyositis
spellingShingle Victoria Riddell
Sarah L Tansley
Bye-bye muscle biopsy, we have autoantibodies with us now
Indian Journal of Rheumatology
autoantibody
biopsy
diagnosis
myopathy
myositis
title Bye-bye muscle biopsy, we have autoantibodies with us now
title_full Bye-bye muscle biopsy, we have autoantibodies with us now
title_fullStr Bye-bye muscle biopsy, we have autoantibodies with us now
title_full_unstemmed Bye-bye muscle biopsy, we have autoantibodies with us now
title_short Bye-bye muscle biopsy, we have autoantibodies with us now
title_sort bye bye muscle biopsy we have autoantibodies with us now
topic autoantibody
biopsy
diagnosis
myopathy
myositis
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=6;spage=74;epage=80;aulast=Riddell
work_keys_str_mv AT victoriariddell byebyemusclebiopsywehaveautoantibodieswithusnow
AT sarahltansley byebyemusclebiopsywehaveautoantibodieswithusnow